V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190006324 | 190001405 | 1.83 | 84.8 | Neo-adjuvant (N) | 2019-11-30 | 2019-12-13 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | CISPLATIN + GEMCITABINE | 101237140 |
| 190006326 | 190001406 | null | null | null | null | 2019-01-15 | Cisplatin | null | null | CISPLATIN | 100485327 |
| 190006328 | 190001408 | 1.7 | 52.4 | null | 2016-09-17 | 2016-09-17 | Carboplatin AUC 2 - 5 | 02 | null | CISPLATIN + RT | 101200531 |
| 190006330 | 190001409 | null | null | null | null | 2018-04-11 | EOX | null | null | HYDROXYCARBAMIDE | 100471399 |
| 190006336 | 190001413 | null | null | null | null | 2019-06-29 | Cisplatin + Radiotherapy | null | null | CISPLATIN | 101007536 |
| 190006341 | 190001416 | null | null | null | null | 2019-10-02 | Cisplatin + Radiotherapy | null | null | CISPLATIN | 100245833 |
| 190006343 | 190001417 | null | null | null | null | 2019-02-15 | Capecitabine + Oxaliplatin 21day | null | null | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 100494984 |
| 190006348 | 190001419 | null | null | null | null | 2018-01-17 | Carboplatin + Etoposide iv&po | null | null | CARBOPLATIN + ETOPOSIDE | 100343613 |
| 190006352 | 190001422 | null | null | null | null | 2019-06-22 | EURAMOS TRIAL | null | null | ECX | 101845389 |
| 190006358 | 190001425 | null | null | null | null | 2016-10-11 | CARBOPLATIN + RT | null | null | CARBOPLATIN + ETOPOSIDE | 100856568 |
| 190006361 | 190001427 | 1.8 | 60.4 | Palliative (P) | 2016-01-22 | 2016-01-24 | MIFAMURTIDE | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101731565 |
| 190006368 | 190001430 | 1.78 | 48.3 | Palliative (P) | 2019-08-21 | 2019-08-21 | Dox + HD Mtx (post PAM) | null | null | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 101201145 |
| 190006372 | 190001432 | 0 | null | Neo-adjuvant (N) | 2016-12-04 | 2016-12-17 | Carboplatin AUC 2 - 5 | 02 | N | OCTREOTIDE | 100073920 |
| 190006380 | 190001435 | 1.72 | 79.8 | Palliative (P) | 2018-03-05 | 2018-03-05 | Cisplatin + Gemcitabine (D 1 & 8) | Y | N | CISPLATIN + GEMCITABINE | 100976331 |
| 190006381 | 190001436 | 1.64 | 54.4 | Palliative (P) | 2019-07-18 | 2019-07-19 | Folfirinox | 02 | N | MPT | 100820427 |
| 190006386 | 190001438 | 0 | 59.6 | null | null | 2016-10-27 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | null | null | IRINOTECAN + MDG | 100178185 |
| 190006400 | 190001441 | null | null | null | null | 2019-11-23 | Cisplatin 7 day | null | null | CISPLATIN | 101169715 |
| 190006405 | 190001443 | 1.62 | 94 | Curative (C) | 2015-03-02 | 2015-03-13 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 02 | N | FLUOROURACIL + OXALIPLATIN | 101780365 |
| 190006406 | 190001444 | 1.67 | 60.4 | Adjuvant (A) | 2018-04-15 | 2018-04-16 | DOXORUBICIN | 02 | null | GC INT GUIDE EXCRANIAL GERMCELL JEB | 100098732 |
| 190006411 | 190001446 | 1.78 | 71.8 | Neo-adjuvant (N) | 2017-01-29 | 2017-02-01 | CARBOPLATIN + PACLITAXEL | 01 | N | CISPLATIN + DOCETAXEL + FLUOROURACIL | 100206576 |
| 190006414 | 190001449 | 1.69 | 52.5 | Neo-adjuvant (N) | 2020-01-16 | 2020-01-18 | Cisplatin + Radiotherapy | N | N | DOCETAXEL | 100176746 |
| 190006427 | 190001454 | null | null | null | null | 2018-12-24 | Folfirinox | null | null | DOCETAXEL | 100809444 |
| 190006431 | 190001455 | null | null | null | null | 2019-04-26 | Cisplatin 7 day | null | null | CISPLATIN | 101753997 |
| 190006440 | 190001457 | null | null | null | null | 2017-05-07 | FLUOROURACIL + OXALIPLATIN | null | null | ECX | 100213886 |
| 190006442 | 190001458 | null | null | null | null | 2019-04-01 | IMATINIB | null | null | CYCLOPHOSPHAMIDE + DOCETAXEL | 100856273 |
| 190006445 | 190001459 | 1.83 | 70 | Neo-adjuvant (N) | 2018-01-23 | 2018-02-17 | CISPLATIN + FLUOROURACIL | N | N | CARBOPLATIN + FLUOROURACIL + STREPTOZOCIN | 100591740 |
| 190006449 | 190001462 | 1.61 | 78.2 | Curative (C) | 2019-11-06 | 2019-11-07 | OST Euramos 1 Closed Trial - AP | 02 | Y | DOXORUBICIN + IFOSFAMIDE | 100040612 |
| 190006454 | 190001466 | 1.78 | 103 | Curative (C) | 2019-10-03 | 2019-10-03 | LUTETIUM-177 | 2 | N | EC | 100646509 |
| 190006455 | 190001467 | 1.66 | 69 | Palliative (P) | 2020-01-15 | 2020-01-29 | EW EuroEwing 2012 Arm B VDC | 02 | N | CISPLATIN + ETOPOSIDE | 100395082 |
| 190006458 | 190001468 | null | null | null | null | 2016-06-07 | CARBOPLATIN + RT | null | null | CARBOPLATIN + PACLITAXEL | 101037918 |
| 190006461 | 190001469 | null | null | null | null | 2017-09-08 | Cisplatin | null | null | ABIRATERONE | 100837595 |
| 190006467 | 190001471 | 1.76 | 74.3 | Curative (C) | 2016-11-22 | 2016-12-05 | CISPLATIN + FLUOROURACIL | 02 | Y | GEMCITABINE | 100638118 |
| 190006470 | 190001474 | null | null | null | null | 2016-11-02 | Cisplatin 7 day | null | null | CISPLATIN | 101572881 |
| 190006472 | 190001476 | 1.88 | 65.3 | null | 2016-02-29 | 2016-03-11 | EOX | 02 | null | FLUOROURACIL | 100280324 |
| 190006475 | 190001478 | null | null | null | null | 2017-10-04 | Cisplatin + Etoposide (3 day) | null | null | CAPECITABINE | 100926004 |
| 190006478 | 190001479 | 1.58 | 119 | Palliative (P) | 2017-01-20 | 2017-02-05 | Carboplatin + Etoposide iv&po | 01 | N | CARBOPLATIN + ETOPOSIDE | 101204835 |
| 190006480 | 190001480 | null | null | null | null | 2019-11-07 | EC | null | null | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 101394109 |
| 190006483 | 190001482 | 1.85 | 88.8 | Palliative (P) | 2017-10-24 | 2017-10-27 | Cisplatin + Radiotherapy | 01 | N | CISPLATIN | 101114251 |
| 190006486 | 190001483 | null | null | null | null | 2016-04-20 | Cisplatin | null | null | CISPLATIN | 101627581 |
| 190006490 | 190001486 | 1.83 | 73 | Palliative (P) | 2018-02-22 | 2018-03-03 | Trial Unspecified | 02 | N | DOXORUBICIN + METHOTREXATE | 100595318 |
| 190006492 | 190001487 | 1.69 | 12.2 | Palliative (P) | 2018-12-18 | 2019-01-05 | CARBOPLATIN + ETOPOSIDE | 02 | null | CARBOPLATIN + ETOPOSIDE | 101205034 |
| 190006496 | 190001489 | 1.8 | 57 | Neo-adjuvant (N) | 2014-05-01 | 2014-05-01 | Trial Unspecified | 02 | N | BLEOMYCIN + CISPLATIN + VINCRISTINE | 101844931 |
| 190006498 | 190001490 | 1.59 | 55.8 | 03 | 2019-01-12 | 2019-01-26 | Cisplatin + Radiotherapy | 02 | N | CISPLATIN | 100803945 |
| 190006500 | 190001491 | 1.7 | 67.15 | Palliative (P) | 2017-02-09 | 2017-02-09 | Carboplatin + Etoposide iv&po | 02 | N | CARBOPLATIN + ETOPOSIDE | 101497334 |
| 190006502 | 190001493 | null | null | null | null | 2018-10-24 | Cisplatin + Gemcitabine (D 1 & 8) | null | null | CISPLATIN + GEMCITABINE | 100425275 |
| 190006504 | 190001495 | 1.8 | 75 | Curative (C) | 2018-01-10 | 2018-01-31 | Cisplatin + Radiotherapy + CISPLATIN | 02 | null | CISPLATIN | 100393116 |
| 190006511 | 190001497 | 0 | 50.5 | Palliative (P) | 2014-02-16 | 2014-02-23 | OCTREOTIDE | 01 | N | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 101718078 |
| 190006513 | 190001498 | 1.53 | 72 | Neo-adjuvant (N) | 2017-11-24 | 2017-12-15 | MAP | 02 | N | LUTETIUM-177 | 100877327 |
| 190006518 | 190001500 | 1.8 | 60 | Adjuvant (A) | 2018-04-26 | 2018-04-30 | CISPLATIN + RT | 02 | N | CISPLATIN | 101648712 |
| 190006519 | 190001501 | 1.65 | 101 | Palliative (P) | 2019-02-01 | 2019-02-25 | CISPLATIN + FLUOROURACIL | 02 | N | ECX | 100406460 |